E-LIB Suche - Ergebnisse für: Mander, Adrian P.

1

Phase 1 safety, tolerability, pharmacokinetics and pharmaco..:

Goncalves, Maria B. ; Mant, Tim ; Täubel, Jörg...
British Journal of Clinical Pharmacology. 89 (2023) 12 - p. 3573-3583 , 2023

Link: https://doi.org/10.1111/..

2

Optimised point estimators for multi-stage single-arm phase..:

Grayling, Michael J. ; Mander, Adrian P.
Journal of Biopharmaceutical Statistics. 32 (2022) 6 - p. 817-831 , 2022

Link: https://doi.org/10.1080/..

3

A stochastically curtailed single‐arm phase II trial design..:

Law, Martin ; Grayling, Michael J. ; Mander, Adrian P.
Journal of Biopharmaceutical Statistics. 32 (2022) 5 - p. 671-691 , 2022

Link: https://doi.org/10.1080/..

4

INNODIA Master Protocol for the evaluation of investigation..:

Dunger, David B. ; Bruggraber, Sylvaine F. A. ; Mander, Adrian P....
Trials. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

5

Subgroup analyses in randomized controlled trials frequentl..:

Williamson, S. Faye ; Grayling, Michael J. ; Mander, Adrian P....
Journal of Clinical Epidemiology. 150 (2022) - p. 72-79 , 2022

Link: https://doi.org/10.1016/..

6

Accounting for variation in the required sample size in the..:

Grayling, Michael J. ; Mander, Adrian P.
Contemporary Clinical Trials. 107 (2021) - p. 106459 , 2021

Link: https://doi.org/10.1016/..

7

The adaptive designs CONSORT extension (ACE) statement: a c..:

Dimairo, Munyaradzi ; Pallmann, Philip ; Wason, James...
Trials. 21 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Designs for adding a treatment arm to an ongoing clinical t..:

Bennett, Maxine ; Mander, Adrian P.
Trials. 21 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

9

The Adaptive designs CONSORT Extension (ACE) statement: a c..:

Dimairo, Munyaradzi ; Pallmann, Philip ; Wason, James...
BMJ. , 2020

Link: https://doi.org/10.1136/..

10

The Adaptive designs CONSORT Extension (ACE) statement: a c..:

Dimairo, Munyaradzi ; Pallmann, Philip ; Wason, James...
BMJ: British Medical Journal. 369 (2020) - p. 1-31 , 2020

Link: https://www.jstor.org/st..

11

A stochastically curtailed two‐arm randomised phase II tria..:

Law, Martin ; Grayling, Michael J. ; Mander, Adrian P.
Pharmaceutical Statistics. 20 (2020) 2 - p. 212-228 , 2020

Link: https://doi.org/10.1002/..

12

A Review of Perspectives on the Use of Randomization in Pha..:

Grayling, Michael J ; Dimairo, Munyaradzi ; Mander, Adrian P.
JNCI: Journal of the National Cancer Institute. 111 (2019) 12 - p. 1255-1262 , 2019

Link: https://doi.org/10.1093/..

13

Designing and evaluating dose-escalation studies made easy:..:

Pallmann, Philip ; Wan, Fang ; Mander, Adrian P...
Clinical Trials. 17 (2019) 2 - p. 147-156 , 2019

Link: https://doi.org/10.1177/..

14

Re-formulating Gehan's design as a flexible two-stage singl..:

Grayling, Michael J. ; Mander, Adrian P.
BMC Medical Research Methodology. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

15

Sample size re-estimation in crossover trials: application ..:

Wych, Julie ; Grayling, Michael J. ; Mander, Adrian P.
Trials. 20 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..